Article Text

PDF

Low dose oral methotrexate treatment of multiple sclerosis: a pilot study.
  1. R D Currier,
  2. A F Haerer,
  3. E F Meydrech
  1. Department of Neurology, University of Mississippi Medical Center, Jackson 39216.

    Abstract

    An 18-month double-blind treatment of multiple sclerosis with low dose oral methotrexate showed it to be well tolerated and suggested effectiveness in exacerbating-remitting MS but not in the exacerbating progressive and chronic progressive stages.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles